Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1968 Sep 28;3(5621):783–785. doi: 10.1136/bmj.3.5621.783

Clinical Trial of 6% Hydroxyethyl Starch (a New Plasma Expander)*

Toriola F Solanke
PMCID: PMC1989559  PMID: 4877738

Abstract

No adverse effects were seen in 29 patients given an intravenous infusion of 6% hydroxyethyl starch solution. Platelet counts had fallen by eight hours after infusion, but had reached pretransfusion levels by 24 hours. Two patients developed unusual bleeding post-operatively, which was possibly due to the infusion. Further investigations on the first stage of coagulation and prothrombin generation in patients receiving hydroxyethyl starch are required.

Full text

PDF
784

Images in this article


Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES